MARKET

LJPC

LJPC

La Jolla Pharm
NASDAQ

Real-time Quotes | Nasdaq Last Sale

10.92
-0.07
-0.64%
After Hours: 10.92 0 0.00% 16:08 09/13 EDT
OPEN
11.03
PREV CLOSE
10.99
HIGH
11.24
LOW
10.51
VOLUME
273.93K
TURNOVER
--
52 WEEK HIGH
22.67
52 WEEK LOW
5.01
MARKET CAP
296.25M
P/E (TTM)
-1.8380
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of LJPC and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

LJPC News

  • 30 Stocks Moving in Monday's Pre-Market Session
  • Benzinga.6d ago
  • La Jolla Pharmaceutical Company Receives European Commission Approval for GIAPREZA (angiotensin II)
  • GlobeNewswire.08/29 14:00
  • La Jolla Pharma up 5% premarket on Giapreza nod in Europe
  • Seeking Alpha - Article.08/29 13:10
  • La Jolla Pharma Recieves European Commission Approval for GIAPREZA
  • Benzinga.08/29 13:04

More

Industry

Biotechnology & Medical Research
+0.20%
Pharmaceuticals & Medical Research
-0.38%

Hot Stocks

Name
Price
%Change

About LJPC

La Jolla Pharmaceutical Company is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies to improve outcomes in patients suffering from life-threatening diseases. LJPC-501 is its formulation of angiotensin II for the potential treatment of catecholamine-resistant hypotension (CRH). It has initiated a Phase III trial of LJPC-501 for the treatment of CRH, called the Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS) Phase III trial. LJPC-401 is its formulation of synthetic human hepcidin for the potential treatment of conditions characterized by iron overload, such as hereditary hemochromatosis, beta thalassemia, sickle cell disease and myelodysplastic syndrome. LJPC-30S is its next-generation gentamicin derivative program that is focused on therapeutics for the potential treatment of serious bacterial infections, as well as rare genetic disorders, such as cystic fibrosis and Duchenne muscular dystrophy.
More

Webull offers La Jolla Pharmaceutical Company (LJPC) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.